Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs
Open accessThe DOI matches its Crossref record; 224 of the 231 references it cites were found in a registry or an index.
Abstract
ATP-binding cassette (ABC) transporters are transmembrane proteins expressed commonly in metabolic and excretory organs to control xenobiotic or endobiotic disposition and maintain their homeostasis. Changes in ABC transporter expression may directly affect the pharmacokinetics of relevant drugs involving absorption, distribution, metabolism, and excretion (ADME) processes. Indeed, overexpression of efflux ABC transporters in cancer cells or bacteria limits drug exposure and causes therapeutic failure that is known as multidrug resistance (MDR). With the discovery of functional noncoding microRNAs (miRNAs) produced from the genome, many miRNAs have been revealed to govern posttranscriptional gene regulation of ABC transporters, which shall improve our understanding of complex mechanism behind the overexpression of ABC transporters linked to MDR. In this article, we first overview the expression and localization of important ABC transporters in human tissues and their clinical importance regarding ADME as well as MDR. Further, we summarize miRNA-controlled posttranscriptional gene regulation of ABC transporters and effects on ADME and MDR. Additionally, we discuss the development and utilization of novel bioengineered miRNA agents to modulate ABC transporter gene expression and subsequent influence on cellular drug accumulation and chemosensitivity. Findings on posttranscriptional gene regulation of ABC transporters shall not only improve our understanding of mechanisms behind variable ADME but also provide insight into developing new means towards rational and more effective pharmacotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In various cancers, including CRC, miRNAs that target ABC transporters have been reported to modulate the chemosensitivity of cancer cells [102,103].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, F., Xue, X., Wei, J., An, Y., Yao, J. J., Cai, H., Wu, J., Dai, C., Qian, Z., Xu, Z., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605724 · Cited by 140
RetractedInitial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216 · cited 1×
“With valuable insights of human genome, many human ABC transporter genes were identi fi ed (Luciani et al., 1994; Allikmets et al., 1996; Klein et al., 1999; Dean et al., 2001; Olsen et al., 2001; Venter et al., 2001).”
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Vieira, J., & Messing, J. (1982) · Gene · doi:10.1016/0378-1119(82)90015-4 · Cited by 6,056
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,981
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Non-coding RNAs and cancer: microRNAs and beyond
Raia, R. M., & Calin, G. A. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e5 · Cited by 3,382
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · cited 3×
“Anthracyclines Doxorubicin (Mechetner et al., 1998) 2.”
BackgroundInfluentialExportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,010
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784 · cited 1×
“…(Lee et al., 2004) to primary miRNAs (pri-miRNAs) which are recognized and cleaved by micro-processor proteins, DROSHA and DGCR8, to generate short-hairpin, precursor miRNAs (pre-miRNAs) within the nucleus (Lee et al., 2003; Denli et al., 2004; Gregory et al., 2004; Wang et al., 2007) (Figure 4).”
BackgroundThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
The Microprocessor complex mediates the genesis of microRNAs
Gregory, R. I., Yan, K.-P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., & Shiekhattar, R. (2004) · Nature · doi:10.1038/nature03120 · Cited by 2,742
Nuclear Export of MicroRNA Precursors
Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E., & Kutay, U. (2004) · Science · doi:10.1126/science.1090599 · Cited by 2,714
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., Hayward, D. C., Ball, E. E., Degnan, B., Müller, P., et al. (2000) · Nature · doi:10.1038/35040556 · Cited by 2,565
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., & Shiekhattar, R. (2005) · Nature · doi:10.1038/nature03868 · Cited by 2,100
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
Ketting, R. F., Fischer, S. E. J., Bernstein, E., Sijen, T., Hannon, G. J., & Plasterk, R. H. A. (2001) · Genes & Development · doi:10.1101/gad.927801 · Cited by 1,852
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Intronic microRNA precursors that bypass Drosha processing
Ruby, J. G., Jan, C. H., & Bartel, D. P. (2007) · Nature · doi:10.1038/nature05983 · Cited by 1,722
Specificity of microRNA target selection in translational repression
Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Lai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473
Decapping and Decay of Messenger RNA Occur in Cytoplasmic Processing Bodies
Sheth, U., & Parker, R. (2003) · Science · doi:10.1126/science.1082320 · Cited by 1,365
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
A dicer-independent miRNA biogenesis pathway that requires Ago catalysis
Cheloufi, S., Dos Santos, C. O., Chong, M. M. W., & Hannon, G. J. (2010) · Nature · doi:10.1038/nature09092 · Cited by 1,149
Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., & Higgins, C. F. (1990) · Nature · doi:10.1038/346362a0 · Cited by 1,145
Ueda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3004 · Cited by 1,063
The Mirtron Pathway Generates microRNA-Class Regulatory RNAs in Drosophila
Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M., & Lai, E. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.028 · Cited by 1,029
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal
Wang, Y., Medvid, R., Melton, C., Jaenisch, R., & Blelloch, R. (2007) · Nature Genetics · doi:10.1038/ng1969 · Cited by 1,025
Self-citationThe role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Berezikov, E., Chung, W.-J., Willis, J., Cuppen, E., & Lai, E. C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.028 · Cited by 799
Human ATP-binding cassette (ABC) transporter family
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 780
Cui, Y., König, J., Buchholz, U., Spring, H., Leier, I., & Keppler, D. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23190-4 · Cited by 676
MRP3, an organic anion transporter able to transport anti-cancer drugs
Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M. L., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6914 · Cited by 645
Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies
Sen, G. L., & Blau, H. M. (2005) · Nature Cell Biology · doi:10.1038/ncb1265 · Cited by 644
Kovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Self-citationAn inventory of the human ABC proteins
Klein, I., Sarkadi, B., & Váradi, A. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00161-3 · Cited by 582
An integrated expression atlas of miRNAs and their promoters in human and mouse
The FANTOM Consortium, de Rie, D., Abugessaisa, I., Alam, T., Arner, E., Arner, P., Ashoor, H., Åström, G., Babina, M., Bertin, N., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3947 · Cited by 561
van Aubel, R. A. M. H., Smeets, P. H. E., Peters, J. G. P., Bindels, R. J. M., & Russel, F. G. M. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133595 · Cited by 501
The complexity of miRNA-mediated repression
Wilczynska, A., & Bushell, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.112 · Cited by 500
Yang, J.-S., Maurin, T., Robine, N., Rasmussen, K. D., Jeffrey, K. L., Chandwani, R., Papapetrou, E. P., Sadelain, M., O'Carroll, D., & Lai, E. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006432107 · Cited by 487
Wijnholds, J., Mol, C. A. A. M., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120159197 · Cited by 478
Tissue distribution of the multidrug resistance protein.
Flens, M. J., Zaman, G. J., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., Scheffer, G. L., van der Groep, P., de Haas, M., Meijer, C. J. L. M., & Scheper, R. J. (1996) · Europe PMC (PubMed Central) · Cited by 473
Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans
Jin, M. S., Oldham, M. L., Zhang, Q., & Chen, J. (2012) · Nature · doi:10.1038/nature11448 · Cited by 465
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C.-G., & Yang, J.-M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 456
Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation
Kim, Y., & Chen, J. (2018) · Science · doi:10.1126/science.aar7389 · Cited by 456
Lipid composition of the cancer cell membrane
Szlasa, W., Zendran, I., Zalesińska, A., Tarek, M., & Kulbacka, J. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09846-4 · Cited by 435
In vitro reconstitution of the human RISC-loading complex
MacRae, I. J., Ma, E., Zhou, M., Robinson, C. V., & Doudna, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710869105 · Cited by 434
Re-evaluation of the roles of DROSHA , Exportin 5 , and DICER in microRNA biogenesis
Kim, Y.-K., Kim, B., & Kim, V. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602532113 · Cited by 427
Bargou, R. C., Jürchott, K., Wagener, C., Bergmann, S., Metzner, S., Bommert, K., Mapara, M. Y., Winzer, K.-J., Dietel, M., Dörken, B., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-447 · Cited by 423
Burger, H., van Tol, H., Boersma, A. W. M., Brok, M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2004) · Blood · doi:10.1182/blood-2004-04-1398 · Cited by 417
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
Leggas, M., Adachi, M., Scheffer, G. L., Sun, D., Wielinga, P., Du, G., Mercer, K. E., Zhuang, Y., Panetta, J. C., Johnston, B., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7612-7621.2004 · Cited by 414
Fromm, M. F., Kim, R. B., Stein, C. M., Wilkinson, G. R., & Roden, D. M. (1999) · Circulation · doi:10.1161/01.cir.99.4.552 · Cited by 402
Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4
Chen, Z.-S., Lee, K., & Kruh, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104833200 · Cited by 396
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Yu, A.-M., Choi, Y. H., & Tu, M.-J. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 395
Self-citationMutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., & Bates, S. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601370 · Cited by 368
A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway
O’Carroll, D., Mecklenbrauker, I., Das, P. P., Santana, A., Koenig, U., Enright, A. J., Miska, E. A., & Tarakhovsky, A. (2007) · Genes & Development · doi:10.1101/gad.1565607 · Cited by 343
Berger, E. A., & Heppel, L. A. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42031-0 · Cited by 340
He, X.-X., Chang, Y., Meng, F.-Y., Wang, M.-Y., Xie, Q.-H., Tang, F., Li, P.-Y., Song, Y.-H., & Lin, J.-S. (2012) · Oncogene · doi:10.1038/onc.2011.500 · Cited by 339
Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 334
Liang, Z., Wu, H., Xia, J., Li, Y., Zhang, Y., Huang, K., Wagar, N., Yoon, Y., Cho, H. T., Scala, S., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.017 · Cited by 330
Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., & Keppler, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50331 · Cited by 324
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
The N domain of Argonaute drives duplex unwinding during RISC assembly
Kwak, P. B., & Tomari, Y. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2232 · Cited by 317
Pan, Y.-Z., Morris, M. E., & Yu, A.-M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054163 · Cited by 309
Self-citationMechetner, E. B., Kyshtoobayeva, A. S., Zonis, S., Kim, H. J., Stroup, R., Garcia, R., Parker, R. J., & Fruehauf, J. P. (1998) · PubMed · Cited by 291
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Kopecka, J., Trouillas, P., Gašparović, A. Č., Gazzano, E., Assaraf, Y. G., & Riganti, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100670 · Cited by 291
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
Self-citationPeetla, C., Vijayaraghavalu, S., & Labhasetwar, V. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.004 · Cited by 289
Imaoka, T., Kusuhara, H., Adachi, M., Schuetz, J. D., Takeuchi, K., & Sugiyama, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028233 · Cited by 277
Bao, L., Hazari, S., Mehra, S., Kaushal, D., Moroz, K., & Dash, S. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.024 · Cited by 275
Keppler, D., & König, J. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.7.9212074 · Cited by 272
Cloning of Two Novel ABC Transporters Mapping on Human Chromosome 9
Luciani, M. F., Denizot, F., Savary, S., Mattei, M. G., & Chimini, G. (1994) · Genomics · doi:10.1006/geno.1994.1237 · Cited by 267
Evers, R., Zaman, G. J., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C., Oude Elferink, R. P., Borst, P., & Schinkel, A. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118535 · Cited by 260
Renes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256
Zeng, H., Chen, Z., Belinsky, M. G., Rea, P. A., & Kruh, G. D. (2001) · PubMed · Cited by 255
Pratt, S., Shepard, R. L., Kandasamy, R. A., Johnston, P. A., Perry, W., & Dantzig, A. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0291 · Cited by 245
Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1
Nosol, K., Romane, K., Irobalieva, R. N., Alam, A., Kowal, J., Fujita, N., & Locher, K. P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010264117 · Cited by 245
Lorico, A., Rappa, G., Finch, R. A., Yang, D. D., Flavell, R. A., & Sartorelli, A. C. (1997) · PubMed · Cited by 241
Dai, Y., Rashba-Step, J., & Cederbaum, A. I. (1993) · Biochemistry · doi:10.1021/bi00078a017 · Cited by 240
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 238
The controversial role of ABC transporters in clinical oncology
Tamaki, A., Ierano, C., Szakacs, G., Robey, R. W., & Bates, S. E. (2011) · Essays in Biochemistry · doi:10.1042/bse0500209 · Cited by 235
Hegedűs, C., Özvegy‐Laczka, C., Apáti, Á., Magócsi, M., Német, K., Őrfi, L., Kéri, G., Katona, M., Takáts, Z., Váradi, A., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00383.x · Cited by 228
Human skeletal muscle drug transporters determine local exposure and toxicity of statins
Knauer, M. J., Urquhart, B. L., Meyer zu Schwabedissen, H. E., Schwarz, U. I., Lemke, C. J., Leake, B. F., Kim, R. B., & Tirona, R. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.203596 · Cited by 222
Huisman, M. T., Smit, J. W., Crommentuyn, K. M., Zelcer, N., Wiltshire, H. R., Beijnen, J. H., & Schinkel, A. H. (2002) · AIDS · doi:10.1097/00002030-200211220-00009 · Cited by 222
Chen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., & Nie, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.030 · Cited by 219
Tiwari, A. K., Sodani, K., Wang, S.-R., Kuang, Y.-H., Ashby, C. R., Chen, X., & Chen, Z.-S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.002 · Cited by 209
ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS
Daood, M., Tsai, C., Ahdab-Barmada, M., & Watchko, J. (2008) · Neuropediatrics · doi:10.1055/s-0028-1103272 · Cited by 209
Hegedűs, T., Őrfi, L., Seprődi, A., Váradi, A., Sarkadi, B., & Kéri, G. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00095-9 · Cited by 207
Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10)
Hopper-Borge, E., Chen, Z.-S., Shchaveleva, I., Belinsky, M. G., & Kruh, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3111 · Cited by 198
Structure and Mechanism of Human ABC Transporters
Alam, A., & Locher, K. P. (2023) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-111622-091232 · Cited by 196
P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib
Chen, Y., Agarwal, S., Shaik, N. M., Chen, C., Yang, Z., & Elmquist, W. F. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154781 · Cited by 194
The human ATP‐binding cassette (ABC) transporter superfamily
Dean, M., Moitra, K., & Allikmets, R. (2022) · Human Mutation · doi:10.1002/humu.24418 · Cited by 187
Rocchi, E., Khodjakov, A., Volk, E. L., Yang, C.-H., Litman, T., Bates, S. E., & Schneider, E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2590 · Cited by 184
Kitazaki, T., Oka, M., Nakamura, Y., Tsurutani, J., Doi, S., Yasunaga, M., Takemura, M., Yabuuchi, H., Soda, H., & Kohno, S. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.035 · Cited by 182
Esser, L., Zhou, F., Pluchino, K. M., Shiloach, J., Ma, J., Tang, W.-K., Gutierrez, C., Zhang, A., Shukla, S., Madigan, J. P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.755884 · Cited by 182
Fan, J., To, K. K. W., Chen, Z.-S., & Fu, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100905 · Cited by 180
Zhang, Y., Schuetz, J. D., Elmquist, W. F., & Miller, D. W. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068528 · Cited by 175
Feng, D., Zhang, H., Zhang, P., Zheng, Y., Zhang, X., Han, B., Luo, X., Xu, L., Zhou, H., Qu, L., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01213.x · Cited by 175
The Genetics of ATP‐Binding Cassette Transporters
Dean, M. (2005) · Methods in Enzymology · doi:10.1016/s0076-6879(05)00024-8 · Cited by 174
Zeng, H., Bain, L. J., Belinsky, M. G., & Kruh, G. D. (1999) · PubMed · Cited by 173
The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin
de Lannoy, I. A. M., & Silverman, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91593-f · Cited by 170
Muriithi, W., Wanjiku Macharia, L., Pilotto Heming, C., Lima Echevarria, J., Nyachieo, A., Niemeyer Filho, P., & Moura Neto, V. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0284 · Cited by 169
Young, L. C., Campling, B. G., Voskoglou-Nomikos, T., Cole, S. P. C., Deeley, R. G., & Gerlach, J. H. (1999) · PubMed · Cited by 168
Identification of homologous microRNAs in 56 animal genomes
Li, S., Chan, W., Hu, L., Lai, C.-H., Hsu, C., & Lin, W. (2010) · Genomics · doi:10.1016/j.ygeno.2010.03.009 · Cited by 167
Poly(A)-Specific Ribonuclease Mediates 3′-End Trimming of Argonaute2-Cleaved Precursor MicroRNAs
Yoda, M., Cifuentes, D., Izumi, N., Sakaguchi, Y., Suzuki, T., Giraldez, A. J., & Tomari, Y. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.029 · Cited by 167
How do miRNAs mediate translational repression?
Gu, S., & Kay, M. A. (2010) · Silence · doi:10.1186/1758-907x-1-11 · Cited by 166
To, K. K. W., Zhan, Z., Litman, T., & Bates, S. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-08 · Cited by 164
RNA therapy: Are we using the right molecules?
Yu, A.-M., Jian, C., Yu, A. H., & Tu, M.-J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.011 · Cited by 163
Self-citationCrespi, C. L., & Miller, V. P. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00028-5 · Cited by 161
Borel, F., Han, R., Visser, A., Petry, H., van Deventer, S. J. H., Jansen, P. L. M., & Konstantinova, P. (2012) · Hepatology · doi:10.1002/hep.24682 · Cited by 154
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
Wang, J., Wu, Z., Yang, Y., Teng, Q., Li, Y., Lei, Z., Jani, K. A., Kaushal, N., & Chen, Z. (2021) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12434 · Cited by 143
Multidrug ABC transporters in bacteria
Orelle, C., Mathieu, K., & Jault, J.-M. (2019) · Research in Microbiology · doi:10.1016/j.resmic.2019.06.001 · Cited by 139
Regulation of ABC transporters at the blood–brain barrier
Miller, D. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.64 · Cited by 137
Norris, M. D., Smith, J., Tanabe, K., Tobin, P., Flemming, C., Scheffer, G. L., Wielinga, P., Cohn, S. L., London, W. B., Marshall, G. M., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0161 · Cited by 135
Li, X., Pan, Y.-Z., Seigel, G. M., Hu, Z.-H., Huang, M., & Yu, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.018 · Cited by 133
Self-citationEvers, R., Piquette‐Miller, M., Polli, J. W., Rüssel, F. G. M., Sprowl, J. A., Tohyama, K., Ware, J. A., de Wildt, S. N., Xie, W., & Brouwer, K. L. R. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1115 · Cited by 132
TRBP ensures efficient Dicer processing of precursor microRNA in RNA-crowded environments
Fareh, M., Yeom, K.-H., Haagsma, A. C., Chauhan, S., Heo, I., & Joo, C. (2016) · Nature Communications · doi:10.1038/ncomms13694 · Cited by 130
Ponchon, L., Beauvais, G., Nonin‐Lecomte, S., & Dardel, F. (2009) · Nature Protocols · doi:10.1038/nprot.2009.67 · Cited by 128
Molecular Mechanism of Chemoresistance by Astrocyte Elevated Gene-1
Yoo, B. K., Chen, D., Su, Z.-Z., Gredler, R., Yoo, J., Shah, K., Fisher, P. B., & Sarkar, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4009 · Cited by 128
Xu, X. T., Xu, Q., Tong, J. L., Zhu, M. M., Nie, F., Chen, X., Xiao, S. D., & Ran, Z. H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.88 · Cited by 123
Williams, G. C., Liu, A., Knipp, G., & Sinko, P. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3456-3462.2002 · Cited by 122
Chen, Z., Ma, T., Huang, C. Z., Zhang, L., Lv, X., Xu, T., Hu, T., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.032 · Cited by 122
MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
Yang, T., Zheng, Z., Li, X., Li, Z.-F., Wang, Y., Geng, Y.-F., Li, B., & Zhang, X. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213497321 · Cited by 121
Self-citationEscape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
To, K. K. W., Robey, R. W., Knutsen, T., Zhan, Z., Ried, T., & Bates, S. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0292 · Cited by 112
Meaden, E. R. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf161 · Cited by 110
Babiarz, J. E., Hsu, R., Melton, C., Thomas, M., Ullian, E. M., & Blelloch, R. (2011) · RNA · doi:10.1261/rna.2442211 · Cited by 109
Su, Y., Zhang, X., & Sinko, P. J. (2003) · Molecular Pharmaceutics · doi:10.1021/mp0340136 · Cited by 108
Micro RNA s and their relevance to ABC transporters
Haenisch, S., Werk, A. N., & Cascorbi, I. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12251 · Cited by 108
Apical ABC Transporters and Cancer Chemotherapeutic Drug Disposition
Durmuş, S., Hendrikx, J. J. M. A., & Schinkel, A. H. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.001 · Cited by 108
Janneh, O., Jones, E., Chandler, B., Owen, A., & Khoo, S. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm353 · Cited by 101
Vanwijngaerden, Y.-M., Wauters, J., Langouche, L., Vander Perre, S., Liddle, C., Coulter, S., Vanderborght, S., Roskams, T., Wilmer, A., Van den Berghe, G., et al. (2011) · Hepatology · doi:10.1002/hep.24582 · Cited by 96
Gao, M., Miao, L., Liu, M., Li, C., Yu, C., Yan, H., Yin, Y., Wang, Y., Qi, X., & Ren, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10845 · Cited by 96
Self-citationDeliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Yu, A., & Tu, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107967 · Cited by 95
Self-citationChung, S., Sawyer, J. K., Gebre, A. K., Maeda, N., & Parks, J. S. (2011) · Circulation · doi:10.1161/circulationaha.111.025445 · Cited by 95
Martino, M. T. D., Arbitrio, M., Leone, E., Guzzi, P. H., Rotundo, M. S., Ciliberto, D., Tomaino, V., Fabiani, F., Talarico, D., Sperlongano, P., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.9.17781 · Cited by 95
miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2
Xu, K., Liang, X., Shen, K., Cui, D., Zheng, Y., Xu, J., Fan, Z., Qiu, Y., Li, Q., Ni, L., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120386 · Cited by 93
Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics
Lagas, J. S., Vlaming, M. L. H., van Tellingen, O., Wagenaar, E., Jansen, R. S., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1352 · Cited by 91
Ikemura, K., Yamamoto, M., Miyazaki, S., Mizutani, H., Iwamoto, T., & Okuda, M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081844 · Cited by 89
de Gooijer, M. C., Zhang, P., Thota, N., Mayayo‐Peralta, I., Buil, L. C. M., Beijnen, J. H., & van Tellingen, O. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0266-y · Cited by 88
Active Efflux of CPT-11 and Its Metabolites in Human KB-Derived Cell Lines
Chu, X.-Y., Suzuki, H., Ueda, K., Kato, Y., Akiyama, S.-I., & Sugiyama, Y. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38014-0 · Cited by 86
Pan, Y.-Z., Zhou, A., Hu, Z., & Yu, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052092 · Cited by 85
Self-citationPotential Role of Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport
Ingelman‐Sundberg, M., Zhong, X., Hankinson, O., Beedanagari, S., Yu, A., Peng, L., & Osawa, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053157 · Cited by 83
Self-citationZeng, C., Dong, F., Xu, Y., Li, X., Yuan, J., Yang, Q., Zhou, X., Lu, J., Zhang, C., Han, J., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113795 · Cited by 82
Chen, Q., Wang, W.-P., Zeng, S., Urayama, S., & Yu, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv228 · Cited by 82
Self-citationMicroRNA profiling in K-562 cells under imatinib treatment
Turrini, E., Haenisch, S., Lächelt, S., Diewock, T., Bruhn, O., & Cascorbi, I. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328350012b · Cited by 82
Yu, A., Tian, Y., Tu, M., Ho, P. Y., & Jilek, J. L. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067470 · Cited by 81
Self-citationHaenisch, S., Lächelt, S., Bruckmueller, H., Werk, A. N., Noack, A., Bruhn, O., Remmler, C., & Cascorbi, I. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070714 · Cited by 81
Fan, Y.-P., Liao, J.-Z., Lu, Y.-Q., Tian, D.-A., Ye, F., Zhao, P.-X., Xiang, G.-Y., Tang, W.-X., & He, X.-X. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.03.010 · Cited by 80
Interaction of Docetaxel (“Taxotere”) with Human P‐Glycoprotein
Shirakawa, K., Takara, K., Tanigawara, Y., Aoyama, N., Kasuga, M., Komada, F., Sakaeda, T., & Okumura, K. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00723.x · Cited by 79
The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma
Zhao, Y., Qi, X., Chen, J., Wei, W., Yu, C., Yan, H., Pu, M., Li, Y., Miao, L., Li, C., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.027 · Cited by 77
Tompkins, L. M., Li, H., Li, L., Lynch, C., Xie, Y., Nakanishi, T., Ross, D. D., & Wang, H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.016 · Cited by 76
Naruhashi, K., Tamai, I., Inoue, N., Muraoka, H., Sai, Y., Suzuki, N., & Tsuji, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.344-349.2002 · Cited by 76
Lemontt, J. F., Azzaria, M., & Gros, P. (1988) · PubMed · Cited by 76
Li, X., Tian, Y. E., Tu, M., Ho, P. Y., Batra, N., & Yu, A. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.12.002 · Cited by 74
Self-citationRole of microRNAs in the regulation of drug metabolism and disposition
Yu, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903307448 · Cited by 73
Self-citationRegulatory Pathways for ATP-binding Cassette Transport Proteins in Kidney Proximal Tubules
Masereeuw, R., & Rüssel, F. G. M. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9404-z · Cited by 73
Yi, W., Tu, M., Liu, Z., Zhang, C., Batra, N., Yu, A.-X., & Yu, A. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.001 · Cited by 72
Self-citationNoncoding microRNAs: small RNAs play a big role in regulation of ADME?
Yu, A., & Pan, Y. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.02.011 · Cited by 72
Self-citationBoscoboinik, D. O., Gupta, R., & Epand, R. M. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.127 · Cited by 70
Sun, K.-X., Jiao, J.-W., Chen, S., Liu, B.-L., & Zhao, Y. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0207-6 · Cited by 70
Shen, T., Kuang, Y.-H., Ashby, C. R., Lei, Y., Chen, A., Zhou, Y., Chen, X., Tiwari, A. K., Hopper-Borge, E., Ouyang, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007520 · Cited by 70
Davey, R., Longhurst, T., Davey, M. W., Belov, L., Harvie, R. M., Hancox, D., & Wheeler, H. (1995) · Leukemia Research · doi:10.1016/0145-2126(94)00159-8 · Cited by 68
Wang, W., Ho, P. Y., Chen, Q., Addepalli, B., Limbach, P. A., Li, M., Wu, W., Jilek, J. L., Qiu, J., Zhang, H., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225631 · Cited by 67
Self-citationBioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Ho, P. Y., Duan, Z., Batra, N., Jilek, J. L., Tu, M., Qiu, J.-X., Hu, Z., Wun, T., Lara, P. N., White, R. D., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.247775 · Cited by 67
Self-citationWang, Y., Zhao, L., Xiao, Q., Jiang, L., He, M., Bai, X., Ma, M., Jiao, X., & Wei, M. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.11.034 · Cited by 66
Self-citationMa, J., Wang, T., Guo, R., Yang, X., Yin, J., Yu, J., Xiang, Q., Pan, X., Tang, H., & Lei, X. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1015536 · Cited by 64
Zhu, X., Li, Y., Shen, H., Li, H., Long, L., Hui, L., & Xu, W. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms099 · Cited by 63
Effect of ABC transporter expression and mutational status on survival rates of cancer patients
Kadioglu, O., Saeed, M. E. M., Munder, M., Spuller, A., Greten, H. J., & Efferth, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110718 · Cited by 60
Li, M.-M., Addepalli, B., Tu, M., Chen, Q., Wang, W.-P., Limbach, P. A., LaSalle, J. M., Zeng, S., Huang, M., & Yu, A. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064493 · Cited by 59
Self-citationThe Growing Class of Novel RNAi Therapeutics
Traber, G. M., & Yu, A. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000895 · Cited by 59
Self-citationSorf, A., Hofman, J., Kučera, R., Štaud, F., & Čečková, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.013 · Cited by 58
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy
Luo, Z., Huang, Y., Batra, N., Chen, Y., Huang, H., Wang, Y., Zhang, Z., Li, S., Chen, C., Wang, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44572-6 · Cited by 54
Self-citationGenomic Clustering Facilitates Nuclear Processing of Suboptimal Pri-miRNA Loci
Shang, R., Baek, S. C., Kim, K., Kim, B., Kim, V. N., & Lai, E. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.009 · Cited by 54
Tu, M., Ho, P. Y., Zhang, Q.-Y., Jian, C., Qiu, J.-X., Kim, E. J.-H., Bold, R. J., Gonzalez, F. J., Bi, H., & Yu, A. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.038 · Cited by 52
Self-citationP‑glycoprotein Limits Ribociclib Brain Exposure and CYP3A4 Restricts Its Oral Bioavailability
Martínez-Chávez, A., van Hoppe, S., Rosing, H., Lebre, M. C., Tibben, M. M., Beijnen, J. H., & Schinkel, A. H. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00475 · Cited by 50
Kis, O., Sankaran‐Walters, S., Hoque, M. T., Walmsley, S. L., Dandekar, S., & Bendayan, R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02278-15 · Cited by 47
MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
Zheng, S., Sun, P., Wang, J.-P., Liu, Y., Gong, W., & Liu, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2752 · Cited by 47
ABCC4 is regulated by microRNA-124a and microRNA-506
Markova, S. M., & Kroetz, D. L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.017 · Cited by 46
Chen, C., Scott, D. O., Hanson, E., Franco, J., Berryman, E. R., Volberg, M. L., & Liu, X. (2003) · Pharmaceutical Research · doi:10.1023/a:1022238506509 · Cited by 43
Fukuda, Y., Takenaka, K., Sparreboom, A., Cheepala, S., Wu, C., Ekins, S., Ambudkar, S. V., & Schuetz, J. D. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.086967 · Cited by 42
Vincent, V., Thakkar, H., Aggarwal, S., Mridha, A. R., Ramakrishnan, L., & Singh, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s186565 · Cited by 42
Epigenetic Regulation of ADME-Related Genes: Focus on Drug Metabolism and Transport
Zhong, X., & Leeder, J. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053942 · Cited by 41
Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models
Jiang, X.-L., Gonzalez, F. J., & Yu, A. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.512294 · Cited by 41
Self-citationJilek, J. L., Zhang, Q.-Y., Tu, M., Ho, P. Y., Duan, Z., Qiu, J., & Yu, A. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.007 · Cited by 40
Self-citationLemos, C., Kathmann, I., Giovannetti, E., Calhau, C., Jansen, G., & Peters, G. J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604980 · Cited by 39
Kim, K., Kim, S., Yu, S. N., PARK, S.-K., Choi, H.-D., Yu, H. S., Ji, J., Seo, Y., & Ahn, S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3633 · Cited by 39
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“In various cancers, including CRC, miRNAs that target ABC transporters have been reported to modulate the chemosensitivity of cancer cells [102,103].”
Multidimensional tumor heterogeneity and its role in therapeutic resistance
Mubin, N., Alnukhali, M., Ahmad, N., Driscoll, J. J., & Ahmad, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1794130 · Cited by 24
Arunrat, N., Mhuantong, W., & Sereenonchai, S. (2025) · Microbial Ecology · doi:10.1007/s00248-025-02598-x · Cited by 13
The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage
Călin, G. A., Hubé, F., Ladomery, M., Delihas, N., Ferracin, M., Poliseno, L., Agnelli, L., Alahari, S. K., Yu, A., & Zhong, X. (2024) · Non-Coding RNA · doi:10.3390/ncrna10060062 · Cited by 16
Self-citationSmall RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions
Cronin, J. M., & Yu, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1720361 · Cited by 17
Self-citation
Metadata
- Authors
- Wang, Y., Tu, M.-J., & Yu, A.-M.
- Affiliations
- University of California, Davis (US)
- Corresponding author
- Yu, Ai-Ming
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2024-07-24
- Volume
- 15
- Pages
- 1423416-1423416
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC11303158
- OpenAlex
- W4400963431
- Cited by
- 21
- References
- 231
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA253230, R01CA225958, P30CA093373)
- National Institute of General Medical Sciences (R35GM140835)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- ABC transporters, drug efflux, microRNA, post-transcriptional regulation, multidrug resistance, drug disposition, pharmacokinetics, ADME, xenobiotic metabolism, chemosensitivity, drug accumulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.